Skip to main content

Table 2 Association between demographic, clinical variables, and anti-psychotic use

From: Prescribing pattern of anti-psychotic medications in patients with dementia in Oman: a retrospective observational study

Variables

Unadjusted analysis

Adjusted analysis

No (n=109)

Yes (n=130)

p-value

OR (95% CI)

p-value

Age group

 60–65 years

19 (17.4)

18 (13.8)

0.628

  

 66–75 years

42 (38.5)

58 (44.6)

 76–85 years

35 (32.1)

43 (33.1)

 > 85 years

13 (11.9)

11 (8.5)

Gender

 Male

51 (46.8)

49 (37.7)

0.188

1.0

 

 Female

58 (53.2)

81 (62.3)

 

1.85 (1.04–3.30)

0.038

Marital status

 Married

80 (74.8)

89 (69.0)

0.612

  

 Divorced

5 (4.7)

8 (6.2)

 Widow/widower

22 (20.6)

32 (24.8)

Dementia type

 Alzheimer’s

80 (74.1)

66 (52.0)

<0.001

  

 LBD*

5 (4.6)

9 (7.1)

 Mixed dementia

9 (8.3)

24 (18.9)

 Vascular dementia

14 (13.0)

17 (13.4)

 Others

-

11 (8.7)

Alzheimer’s dementia

 Non-Alzheimer’s Dementia

80 (74.1)

66 (52.0)

<0.001

1.0

 

28 (25.9)

61 (48.0)

 

2.77 (1.52–5.04)

<0.001

Severity of dementia

 Mild stage

38 (34.9)

21 (16.2)

<0.001

1.0

 

 Moderate stage

34 (31.2)

33 (25.4)

 

2.01 (0.93–4.37)

0.076

 Severe stage

37 (33.9)

76 (58.5)

 

4.47 (2.18–9.18)

<0.001

Use of Anti-dementia

 No

98 (89.9)

104 (80.0)

0.047

  

 Yes

11 (10.1)

26 (20.0)

   

Comorbid medical or mental conditions

 No

98 (89.9)

104 (80.0)

0.047

1.0

 

 Yes

11 (10.1)

26 (20.0)

 

2.54 (1.11–5.78)

0.027

  1. LBD Lewy body dementia